跳至主要内容
临床试验/NL-OMON47936
NL-OMON47936招募中2 期

Atosiban as a potential treatment for endometriosis - ENDOBAN pilot-study

Radboud Universitair Medisch Centrum0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Laparoscopic, MRI or ultrasound confirmed endometriosis
  • - Dysmenorrhea with painscore >=5 during menstrual period or withdrawal bleeding
  • - Age between 18 and 45 years old

排除标准

  • - Inability to come to the hospital for the experiment
  • - Suspicion on a (post)menopausal state
  • - Continuous treatment with oral contraceptives or progestagens
  • - Current use of GnRh antagonist
  • - Current ovarian stimulation
  • - Current breastfeeding
  • - Labour or breastfeeding within the last 6 weeks
  • - Diagnosis of chronic pelvic pain
  • - Inability to give informed consent
  • - Language barrier
  • - Diabetes Mellitus, type I or II
  • - Hypersensitivity to atosiban or mannitol
  • - Use of systemic betamimetics
  • - Use of calcium channel blockers

研究者

相似试验